骨髓纤维化的发病机制及临床表现.pdf

刘博雅,等骨髓纤维化的发病机制及临床表现
朝甫,张涛,武晓岩,等.代谢组学数据分析的统计学方法
for ovarian cancer by urinary metabolomic profiling [J]. J Pro-
[J].中国卫生统计,2014,31(2):357-359.
tome Res,2012,12(1):505-512
15] Goodacre R, Broadhurst D, Smilde AK, et al. Proposed minimum [26] Wu ZY, Jia HX, Zhu J, et al. Set of data for ovarian cancer metab-
reporting standards for data analysis in metabolomics[ J]. Metabo-
slied research
Chini Health
logics,2007,3(3):231
2012,29(6):786-789.[武振宇,贾慧珣,朱骥, Boosting算法
I 16 Kirwan JA, Weber RJM, Broadhurst DI, el al. Direct infusion mass
对卵巢癌代谢组数据的应用研究[J].中国卫生统计,2012,29
spectrometry metabolomics dataset: a benchmark for dala process-
(6):786-789.」
ntrol
ific Data,2014,1:140
127] Zhang T, Wu X, Yin M, et al
17] Linger JJ Chylla RA, Ulrich EL, et al. Databases and software
and benign ovarian tumors by plasma metabolomic profiling using
for Nmr-based metabolomics[ J]. Current Metabolomics, 2013
ultra performance liquid chromatography/mass spectrometry[ J
1(1):10
Clinica Chimica Acta, 2012, 413(9): 861-868
18] Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0the human 28 Denkert C, Budczies J, Kind T, et al. Mass spectrometry-based
metabolome database in 2013 [J ]. Nucleic Acids Res, 2013, 41
metabolic profiling reveals di erent metabolite patterns in invasive
D801-D807
ovarian carcinomas and ovarian borderline tumors [ J]. Cancer
[19; Schultz AW, Wang J, Zhu 7J, et al. Liquid chromatography qua
Res,2006,66(22):10795-10804.
drupole time-of -fight characterization of metabolites guided by [29 Garcia E, Andrews C, Hua J, et al. Diagnosis of early stage ovarian
the METLIN database J]. Nature Protocols, 2013, 8(3): 45
cancer by 1H NMR metabonomics of serum explored by use of a
20] Kopka J, Schauer N, Krueger S, et al. Metabolome database[ J]
microflow NMR probelj]. J Proteome Res, 2011, 10(4) 1765
Bioinformatics,2005,21(8):1635-1638
21 J Johnson SR, Lange BM Open-access metabolomics databases for 0 Ha Y Ovarian cancer patients urine and Hela disposed by tax-
natural product research present capabilities and future potential
ol(TAX metabonomies analysis I D]. Shandong U
Universal
[]. Frontiers in Bioengineering and Biotechnol, 2015, 3: 22
2014.[郝秀玉卵巢癌患者尿液及紫杉醇处理Hela细胞的
122 Fahy E, Sud M, Cotter D, et al. LIPID MAPS online tools for lipid
代谢组学分析[D].山东大学,2014.
research[ J ] Nucleic Acids Res, 2007, 35(suppl 2) W606
[31] Caneba CA, Bellance N, Yang L,, et al. Pyruvate uptake is in
creased in highly invasive ovarian cancer cells under anoikis con
proton nuclear magnetic resonance spectroscopy of ov
Am J Physiol -Endocrinol Metabolism, 2012, 303(8): E1036
Fluid[ J]. NMR in Biomedicine, 2000, 13(5): 297-305
E1052
[24] Chen J, Zhou L, Zhang X, et al. Urinary hydrophilic and hydropho- [32] Su Y. The application of metabonomics technology in ovarian
bic metabolic profiling based on liquid chromatography-mass
cancer research [J J. Diagnosis Treat Practical Magazine, 2014
spectrometry methods: Differential metabolite discovery specific
28(12):1152-1154.[苏瑶,李佩玲,代谢组学技术在卵巢
ovarian cancer J]. Electrophoresis, 2012, 33(22): 3361-3369
肿瘤研究中的应用[J].中华实用诊断与治疗杂志,2014,28
[25 Zhang T, Wu X, Ke C, et al. Identification of potential biomarkers
(12):1152-1154.」
编校;谈静)
骨髓纤维化的发病